New Zealand markets open in 7 hours 41 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
368.21+3.20 (+0.88%)
As of 10:17AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 26.59B
Enterprise value 26.29B
Trailing P/E 48.16
Forward P/E 48.78
PEG ratio (5-yr expected) 6.58
Price/sales (ttm)9.34
Price/book (mrq)9.92
Enterprise value/revenue 8.98
Enterprise value/EBITDA 32.18

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 30.38%
S&P500 52-week change 322.38%
52-week high 3415.73
52-week low 3310.42
50-day moving average 3377.23
200-day moving average 3370.76

Share statistics

Avg vol (3-month) 3532.38k
Avg vol (10-day) 3571.93k
Shares outstanding 572.84M
Implied shares outstanding 673.21M
Float 872.35M
% held by insiders 10.57%
% held by institutions 196.74%
Shares short (15 Apr 2024) 4975.86k
Short ratio (15 Apr 2024) 42.72
Short % of float (15 Apr 2024) 41.75%
Short % of shares outstanding (15 Apr 2024) 41.34%
Shares short (prior month 15 Mar 2024) 41.21M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.22%
Trailing annual dividend rate 30.78
Trailing annual dividend yield 30.21%
5-year average dividend yield 40.26
Payout ratio 410.29%
Dividend date 307 Aug 2024
Ex-dividend date 431 Jul 2024
Last split factor 22:1
Last split date 327 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.42%
Operating margin (ttm)18.06%

Management effectiveness

Return on assets (ttm)11.40%
Return on equity (ttm)20.84%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.55
Quarterly revenue growth (yoy)-3.00%
Gross profit (ttm)N/A
EBITDA 809.6M
Net income avi to common (ttm)568.7M
Diluted EPS (ttm)7.59
Quarterly earnings growth (yoy)-17.60%

Balance sheet

Total cash (mrq)601.8M
Total cash per share (mrq)8.26
Total debt (mrq)306.6M
Total debt/equity (mrq)11.44%
Current ratio (mrq)2.61
Book value per share (mrq)36.72

Cash flow statement

Operating cash flow (ttm)756.6M
Levered free cash flow (ttm)143.34M